White House Approaches Agreement to Reduce Obesity Drug Prices and Expand Medicare Coverage
TL;DR
The White House is close to a deal with Eli Lilly and Novo Nordisk to lower the cost of weight loss drugs Zepbound and Wegovy to as little as $149 a month, in exchange for limited Medicare coverage, as part of efforts to reduce prescription drug prices.
Topics:businesshealth#drug-pricing#glp-1-medications#health#medicare-coverage#price-reduction#weight-loss-drugs
- White House nears deal to lower prices for weight loss drugs NBC News
- White House nears deal to lower obesity drug prices for Medicare coverage The Washington Post
- Eli Lilly, Novo Nordisk close to White House deal on obesity drug prices ABC News
- Trump close to deal to allow Medicare coverage of weight loss drugs Axios
- Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, media reports Reuters
Want the full story? Read the original reporting
Read on NBC News